Acorah Software Products - Accounts Production 16.4.675 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 12520456 Mrs. Zeqin Lin iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12520456 2024-03-31 12520456 2025-03-31 12520456 2024-04-01 2025-03-31 12520456 frs-core:CurrentFinancialInstruments 2025-03-31 12520456 frs-core:ShareCapital 2025-03-31 12520456 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 12520456 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12520456 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 12520456 frs-bus:SmallEntities 2024-04-01 2025-03-31 12520456 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 12520456 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12520456 frs-bus:Director1 2024-04-01 2025-03-31 12520456 frs-countries:EnglandWales 2024-04-01 2025-03-31 12520456 2023-03-31 12520456 2024-03-31 12520456 2023-04-01 2024-03-31 12520456 frs-core:CurrentFinancialInstruments 2024-03-31 12520456 frs-core:ShareCapital 2024-03-31 12520456 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 12520456
All4health Lab(UK) Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
TaxAssist Accountants
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 12520456
2025 2024
Notes £ £ £ £
CURRENT ASSETS
Stocks 4 251 3,613
Debtors 5 161 25
Cash at bank and in hand 14,941 761
15,353 4,399
Creditors: Amounts Falling Due Within One Year 6 (14,850 ) (500 )
NET CURRENT ASSETS (LIABILITIES) 503 3,899
TOTAL ASSETS LESS CURRENT LIABILITIES 503 3,899
NET ASSETS 503 3,899
CAPITAL AND RESERVES
Called up share capital 7 1 1
Profit and Loss Account 502 3,898
SHAREHOLDERS' FUNDS 503 3,899
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mrs. Zeqin Lin
Director
25/07/2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
All4health Lab(UK) Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12520456 . The registered office is 304 High Street, Orpington, Kent, BR6 0NF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
4. Stocks
2025 2024
£ £
Finished goods 251 3,613
5. Debtors
2025 2024
£ £
Due within one year
VAT 161 25
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Bank loans and overdrafts - 25
Accruals and deferred income 454 475
Director's loan account 14,396 -
14,850 500
Page 2
Page 3
7. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 1 1
Page 3